Birefringence microscopy enables rapid, label-free quantification of myelin debris following induced cortical injury
Neurophotonics · 28.10.2025 · 12 (04) · 1-20
DOI: 10.1117/1.nph.12.4.045006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurophotonics, erschienen am 28.10.2025. Verfasst von Alexander J Gray und 5 weiteren Autor:innen. Beteiligte Einrichtung: Boston University College of Engineering, Department of Biomedical Engineering, Boston, Massachusetts, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
SignificanceMyelin breakdown is prevalent in a range of neurodegenerative diseases, aging, and following various forms of trauma. Yet, current imaging techniques have limited capacity for large-scale study of myelin structural damage. A high-throughput, quantitative imaging method would greatly enhance our understanding of myelin degradation in different contexts.AimWe aim to establish birefringence microscopy (BRM) as a high-throughput, label-free imaging technique for large-scale, quantitative assessment of myelin pathology in post-mortem brain tissue. BRM has the capacity to provide rapid myelin imaging, which will provide information complementary to other myelin imaging techniques.ApproachBRM enables label-free structural imaging of myelin with high spatial resolution. We leverage the high-throughput imaging capability of BRM to characterize the distribution of myelin pathology in a rhesus monkey model of cortical injury across the corpus callosum. This framework is applied at two different post-injury survival times (6 and 12 weeks).ResultsWe validate BRM for label-free structural imaging of myelin pathology across large regions of tissue (within the corpus callosum) using a fluorescent myelin stain and several immunohistochemical labels. Next, we train and validate a deep learning-based object detection network for automated identification of myelin pathology, using BRM, in the corpus callosum of monkeys with an induced cortical lesion. BRM, paired with deep learning, revealed significantly higher myelin damage through the corpus callosum, resulting from the lesion, in 6-week recovery monkeys compared with 12-week recovery and age-matched controls (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Boston University College of Engineering, Department of Biomedical Engineering, Boston, Massachusetts, United States.
- Boston University, Center for Systems Neuroscience, Boston, Massachusetts, United States.
- Boston University School of Medicine, Department of Anatomy and Neurobiology, Boston, Massachusetts, United States.
- Boston University College of Engineering, Department of Electrical and Computer Engineering, Boston, Massachusetts, United States.
ORCID-Profile: Alexander J Gray, Rhiannon E Robinson, Samer A Berghol, Douglas L Rosene, Irving J Bigio
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- NIH HHS
- National Institutes of Health
- U.S. National Institutes of Health
- Boston University Office of Research
Zitieren
APA
Gray, A. J., Robinson, R. E., Berghol, S. A., Rosene, D. L., Moore, T. L., & Bigio, I. J. (2025). Birefringence microscopy enables rapid, label-free quantification of myelin debris following induced cortical injury. Neurophotonics, 12(04), 1-20. https://doi.org/10.1117/1.nph.12.4.045006
Vancouver
Gray AJ, Robinson RE, Berghol SA, Rosene DL, Moore TL, Bigio IJ. Birefringence microscopy enables rapid, label-free quantification of myelin debris following induced cortical injury. Neurophotonics. 2025;12(04):1-20. doi:10.1117/1.nph.12.4.045006
BibTeX
@article{Gray2025,
author = {Gray, Alexander J and Robinson, Rhiannon E and Berghol, Samer A and Rosene, Douglas L and Moore, Tara L and Bigio, Irving J},
title = {Birefringence microscopy enables rapid, label-free quantification of myelin debris following induced cortical injury},
journal = {Neurophotonics},
year = {2025},
volume = {12},
number = {04},
pages = {1--20},
doi = {10.1117/1.nph.12.4.045006}
}
EUVIMED